SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 446.39 |
| Enterprise Value ($M) | -84.29 |
| Book Value ($M) | 532.84 |
| Book Value / Share | 13.15 |
| Price / Book | 0.84 |
| NCAV ($M) | 505.61 |
| NCAV / Share | 12.48 |
| Price / NCAV | 0.88 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.33 |
| Return on Assets (ROA) | -0.49 |
| Return on Equity (ROE) | -0.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.03 |
| Current Ratio | 19.03 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 552.05 |
| Assets | 579.27 |
| Liabilities | 46.44 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Alkeon Capital Management Llc | |||
| 13G/A | Fmr Llc | |||
| 13G/A | BlackRock, Inc. | 6.80 | 24.32 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 166,614 | 771,036 | 21.61 | |
| 213,580 | 754,275 | 28.32 | |
| 162,066 | 782,476 | 20.71 | |
| 129,090 | 663,692 | 19.45 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KALV – KalVista Pharmaceuticals, Inc. | KLTO – Klotho Neurosciences, Inc. |
| KOD – Kodiak Sciences Inc. | KYMR – Kymera Therapeutics, Inc. |
| LGND – Ligand Pharmaceuticals Incorporated |
Financial data and stock pages provided by
Fintel.io